- Home
- MMLP vs ATRA Comparison
MMLP vs ATRA Comparison
Compare MMLP & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMLP | ATRA |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.6M | 99.1M |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MMLP | ATRA |
|---|---|---|
| Price | $2.60 | $14.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 12.8K | ★ 60.7K |
| Earning Date | 10-15-2025 | 11-12-2025 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | ★ $713,263,000.00 | $151,930,000.00 |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.38 |
| Revenue Growth | N/A | ★ 51.27 |
| 52 Week Low | $2.49 | $5.01 |
| 52 Week High | $4.02 | $18.71 |
Technical Indicators
Market Signals| Indicator | MMLP | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 53.90 |
| Support Level | $2.55 | $12.05 |
| Resistance Level | $2.62 | $15.12 |
| Average True Range (ATR) | 0.06 | 1.06 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 0.00 | 70.59 |
Price Performance
Historical ComparisonAbout MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).